Author: news22

Categories
Health

Helping Canadians access safe, effective treatments and medicines faster


July 15, 2026 | Ottawa, Ontario | Health Canada

Canadians expect timely access to safe and effective drugs and medical devices. Health Canada is taking practical steps to modernize and improve the efficiency of its regulatory processes, while maintaining its high standards for safety, efficacy, and quality.

Over the last three months, Health Canada has approved 537 new drugs and medical devices to help Canadians manage and treat a range of health issues. This includes three generic versions of semaglutide, the first G7 country to do so.

In addition, to help bring more medications and treatments to Canada sooner, Health Canada has published a Ministerial Reliance Order. The Order allows the department to review certain parts of drug submissions faster by using decisions or documents produced by select foreign regulators. This approach maintains Canada’s requirements for safety, efficacy and quality, while reducing unnecessary duplication. A more efficient process will also encourage manufacturers to bring products to Canada. The first classes of drugs that will be accepted by Health Canada under the Order include drugs for pediatric use and veterinary drugs.

At the same time, Health Canada is seeking feedback on a proposed approach to prioritize the review of certain generic drug submissions that involve Canadian manufacturing. Supporting Canada’s generic pharmaceutical and life sciences sector will play a key role in enhancing the security of the drug supply and preventing harmful shortages that could negatively impact the health of Canadians.

Complementing Health Canada’s regulatory modernization efforts, the Canadian Institutes of Health Research (CIHR) continues to support health research and clinical trials that generate the evidence needed to evaluate new drugs, medical devices and other health products, helping strengthen Canada’s life sciences ecosystem and improve access to innovative treatments for Canadians.

These initiatives are helping build a more modern and efficient regulatory system—one that supports faster and expanded access to drugs for Canadians, without compromising Canada’s high standards for safety, efficacy and quality.



Source link

Categories
Health

Drugs and medical devices authorized, April 1 to June 30, 2026


Backgrounder

July 2026

From April 1 to June 30, 2026, Health Canada approved 15 new drug submissions (8 pharmaceuticals, 7 biologics) and 481 new medical devices, including 22 Class IV medical devices, which present the greatest potential risk. During this period, Health Canada also approved 31 generic drugs and 10 biosimilar drugs.

New and innovator drug approvals
Date Drug Purpose
June 26, 2026 Vimkunya Vaccine for Chikungunya
June 22, 2026 Boey Muscle relaxants
June 15, 2026 Exdensur Drugs for obstructive airway diseases
June 12, 2026 Pimjetmi Antineoplastic agents
June 10, 2026 Lupin-Glugacon Pancreatic hormones
June 3, 2026 Idvynso Antivirals for systemic use
May 29, 2026 Loargys Other alimentary tract and metabolism products
May 15, 2026 Thyconvi Thyroid therapy
May 14, 2026 Iheezo Ophthalmologicals
April 30, 2026 Kisunla Psychoanaleptics
April 16, 2026 Tevimbra Antineoplastic agents
April 10, 2026 Lunsumio SC Antineoplastic agents
April 10, 2026 Vueway Contrast media
April 9, 2026 Yeytuo Antivirals for systemic use
April 9, 2026 neffy Drugs for obstructive airway diseases
New Class IV medical device approvals
Date Medical Device Purpose
June 30, 2026 Visualase V2 MRI-guided laser ablation system Tool for neurosurgery
June 29. 2026 Epic Elite/Epic Supra G3 stented porcine tissue valve and sizers Replacement of heart valve
June 29, 2026 Alinity S CMV IGG qualitative assay Diagnostic and screening test kit for cytomegalovirus
June 24, 2026 SGTi-flex COVID-19 & flu A/B Ag Combo Point of care testing kit for COVID-19 and flu
June 10, 2026 cobas Respiratory flex Test to help in the diagnosis of respiratory infections
June 4, 2026 Seprafilm adhesion barrier For use in surgery to reduce internal organ adhesions
June 3, 2026 Affera ablation system Mapping and treatment of an abnormal heart beat
June 2, 2026 Shockwave intravascular lithotripsy (IVL) system with shockwave C2 aero coronary IVL catheter Treatment of heart disease
May 29, 2026 Jade plus PTA balloon dilatation catheter Treatment of heart disease
May 27, 2026 COVID-19 & Influenza A/B&RSV Antigen Pen Home Test Home testing kit for COVID-19, flu and RSV
May 26, 2026 Procleix Babesia Assay Test kit for screening blood, organ and tissue donors for Babesia
May 26, 2026 iVascular iCover, ballon expandable covered peripheral stent system Treatment of blood vessel diseases
May 26, 2026 cobas Microbial Inactivation Solution Preparation of testing specimens
May 26, 2026 Automated external defibrillator Automated external defibrillator for public use
May 6, 2026 Alinity i Anti-HCV Next Assay Test kit to help in diagnosis and donor screening for Hepatitis C
May 5, 2026 Simplexa COVID-19/flu A/B & RSV direct assay Testing kit to help in diagnosis of COVID-19, flu and RSV infections
May 4, 2026 iStatis Hepatitis B Surface Antigent (HBsAg) Test/iStatis Hepatitis B Surface Antigent (HBsAg) Test Controls Point of care test kit to help in diagnosis of Hepatitis B infections
April 27, 2026 NUVISION ultrasound catheter Imaging of heart or blood vessels
April 24, 2026 Supraflex sirolimus eluting stent system Treatment of heart disease
April 16, 2026 Scoreflex TRIO Balloon Dilatation Catheter Treatment of narrowing in heart arteries to improve blood flow
April 15, 2026 Cobas liat system Testing kit to help in diagnosis of COVID-19, flu and RSV infections
April 1, 2026 Volt PFA catheter, sensor enabled Treatment of heart disease

For more information on these and other drug and medical device approvals, consult:

  • The Drug Product Database, which contains product-specific information on drugs that have been approved for use in Canada such as their availability and product monograph.
  • The Medical Devices Active Licence Listing (MDALL) database, which contains the complete list of all medical devices that have been authorized for sale in Canada.
  • Medical devices in Canada are classified from Class I to Class IV based on the level of risk they pose. Class IV devices represent the highest-risk category and are subject to a rigorous pre-market review by Health Canada to ensure that they meet safety, effectiveness and quality requirements before they can be sold in Canada.



Source link

Categories
Alberta

Seizure of contraband and unauthorized items at Drumheller Institution


July 13, 2026 – Drumheller, Alberta – Correctional Service Canada

On July 8, 2026, as a result of the vigilance of staff members, packages containing contraband and unauthorized items were seized at Drumheller Institution.

The contraband and unauthorized items seized included methamphetamine, chargers as well as vaping devices and accessories. The total estimated institutional value of this seizure is $944,860.

The police have been notified and the institution is investigating.

The Correctional Service of Canada (CSC) uses a number of tools to prevent drugs from entering its institutions. These tools include ion scanners and drug-detector dogs to search buildings, personal property, inmates, and visitors.

CSC is heightening measures to prevent contraband from entering its institutions in order to help ensure a safe and secure environment for everyone. CSC also works in partnership with the police to take action against those who attempt to introduce contraband into correctional institutions.

CSC has also set up a telephone tip line for all federal institutions so that it may receive additional information about activities relating to security at CSC institutions. These activities may be related to drug use or trafficking that may threaten the safety and security of visitors, inmates, and staff members working at CSC institutions.

The toll-free number, 1‑866‑780‑3784, helps ensure that the information shared is protected and that callers remain anonymous. 



Source link

Categories
Uncategorized

Government of Canada powering long-term sustainability and Indigenous knowledge sharing at Blackfoot Crossing Historical Park


PrairiesCan investment helping Blackfoot Crossing Historical Park maximize the economic, operational and environmental benefits of solar energy so the site can continue to reliably deliver Indigenous experiences

July 13, 2026 – Siksika, AB – PrairiesCan

The heritage, resilience and determination of Indigenous Peoples are vital to Canada’s identity. It is more important now than ever before that we protect and present the history of how Canada came to be and who we are today. Recognizing the importance of cultural preservation and Indigenous tourism, the Government of Canada is making targeted investments to help share authentic Indigenous stories and support economic reconciliation while enabling rural prosperity.

Today, MP Duguid, MP for Winnipeg South, on behalf of the Honourable Eleanor Olszewski, Minister of Emergency Management and Community Resilience and Minister responsible for Prairies Economic Development Canada (PrairiesCan), toured Blackfoot Crossing Historical Park (Blackfoot Crossing). As part of this tour, MP Duguid announced a $93,000 federal investment to help Blackfoot Crossing undertake community engagements and investigate potential site options for a new solar energy development. This project will ensure the Siksika community is meaningfully engaged in this solar energy development so that economic, operational and environmental benefits can be fully realized.

Funding announced today is delivered by PrairiesCan through the Alberta Indigenous Clean Energy Initiative, a Strategic Partnerships Initiative (SPI). SPI projects are led by Indigenous Services Canada to help create new partnerships and strengthen the federal government’s role in supporting Indigenous economic growth.

This project will ensure that Blackfoot Crossing can continue delivering economic contributions for the people of the Siksika Nation and will enable activities that share the resilience of Indigenous Peoples from this National Heritage Site for generations to come.



Source link

Categories
Health

Canada and Quebec build on partnership to strengthen youth mental health


July 13, 2026 | Montreal, QC | Health Canada

Young people across Canada are struggling with their mental health. Timely access to the right services and supports within their communities can help create lasting and meaningful improvements in the mental health of youth and for their families.

Today, the Honourable Marjorie Michel, Minister of Health, and Lionel Carmant, Quebec’s Minister Responsible for Social Services and the Fight Against Homelessness, announced a new agreement that will provide the Province of Quebec with $70.8 million over four years through the Youth Mental Health Fund.

This investment will help Quebec strengthen the networks of Integrated Youth Services (IYS). It aims to improve equitable access to comprehensive health care—both physical and mental—in order to better meet the needs of young people and promote their well-being. Thanks to this support, more youth facing physical or mental health challenges will be able to access the services they need. Many of these youth, who are often underserved, face disproportionate barriers to accessing high-quality care.

This funding will, among other things, make it possible to expand Quebec’s Aire Ouverte model. Youth will have access to a range of services in one place, including mental health and substance use support, physical and sexual health, youth and family peer support, and social services. Established in 2018, Quebec’s Aire Ouverte IYS model offers comprehensive services, including mental health services, to young people aged 12 to 25 in a free and confidential manner.

The government of Canada, in collaboration with the government of Quebec, remains committed to supporting the mental health of young people everywhere in Canada, providing them with timely access to services and supports in their communities.



Source link

Categories
Uncategorized

Federal Government agreement paves the way for new permanent home for Manitou Asinîy’s in Elk Island National Park


July 13, 2026               Fort Saskatchewan, Alberta                      Parks Canada

In a milestone agreement between the federal government and the Manitou Asinîy – Iniskim – Tsa Xani Centre (MAITX), an Indigenous-led non-profit, Manitou Asinîy (also known as the Manitou Stone) is one step closer to being returned to the land under the stewardship of Indigenous Peoples. Today, the Honourable Julie Dabrusin, Minister of Environment, Climate Change and Nature, the Honourable Eleanor Olszewski, Minister of Emergency Management and Community Resilience and Minister responsible for Prairies Economic Development Canada,  and representatives from MAITX gathered in Elk Island National Park to mark the signing of a Memorandum of Understanding securing land in Elk Island National Park for MAITX to establish a permanent home for the Manitou Stone and allowing for a future Indigenous-led cultural experience within Elk Island National Park. The Manitou Stone is an ancient sacred stone that once served as a gathering place where tribes came to perform spiritual and ceremonial practice. The stone was revered as a source of strength and guidance, embodying the prosperity and balance represented by the bison. MAITX is securing a home for the Manitou Stone on the land surrounded once again by bison in Elk Island National Park – the centre of bison conservation in Canada for over a century. Through this agreement, the care and presentation of the Manitou Stone and its teachings will be fully led by Indigenous Peoples through MAITX.

The federal government is committed to ensuring Indigenous connections are honoured. By partnering with Indigenous-led organizations like MAITX, Parks Canada is demonstrating commitment to working with Indigenous Peoples to conserve cultural heritage and ensure these vital connections with the land are maintained. 

                                                                                                     -30-



Source link